HOW I DO IT DIFFERENTLY?
|Year : 2019 | Volume
| Issue : 4 | Page : 357-359
Double indocyanine green technique of robotic right colectomy: Introduction of a new technique
Jarek Kobiela1, Emilio Bertani2, Wanda Petz3, Cristiano Crosta3, Giuseppe De Roberto3, Simona Borin3, Dario Ribero2, Diana Baldassari2, Piotr Spychalski1, Giuseppe Spinoglio2
1 Medical University of Gdansk, General, Endocrine and Transplant Surgery, Gdansk, Poland
2 European Institute of Oncology (IEO), Hepatobiliary, Pancreatic and Digestive Program, Milan, Italy
3 European Institute of Oncology (IEO), Division of Endoscopy, Milan, Italy
|Date of Submission||18-May-2018|
|Date of Acceptance||23-May-2018|
|Date of Web Publication||10-Sep-2019|
Department of General, Endocrine and Transplant Surgery, Medical University of Gdansk, 3A Sklodowskiej Str., 80-210 Gdansk
Source of Support: None, Conflict of Interest: None
In robotic right hemicolectomy for colorectal cancer (CRC), appropriate lymphadenectomy and anastomotic leak prevention are critical. Visualisation of lymph nodes and blood flow with near-infrared (NIR) fluorescence DaVinci® imaging system is a recent development. Herein, we present an improved robotic modified complete mesocolic excision (mCME) technique using indocyanine green (ICG) fluorescence. Before surgery, ICG is injected into the submucosa around the tumour with endoscopy for intraoperative detection of lymph nodes. Robotic mCME with central vascular ligation is performed, supplemented in most of the cases with selective extended lymphadenectomy. Intestinal blood flow before anastomosis is evaluated by administering ICG intravenously and NIR visualisation. Visualisation of the lymph nodes with ICG facilitates standard mCME lymphadenectomy and enables extended lymphadenectomy. Blood flow of the intestinal walls of the anastomotic site can be assessed and determines the extent of intestinal resection. Robotic double ICG technique for robotic right hemicolectomy enables improved lymphadenectomy and warrants the extent of intestinal resection; thus, becoming a strong candidate for gold standard in robotic resections of the right colon for CRC.
Keywords: Complete mesocolic excision, da Vinci Xi system, right hemicolectomy
|How to cite this article:|
Kobiela J, Bertani E, Petz W, Crosta C, De Roberto G, Borin S, Ribero D, Baldassari D, Spychalski P, Spinoglio G. Double indocyanine green technique of robotic right colectomy: Introduction of a new technique. J Min Access Surg 2019;15:357-9
|How to cite this URL:|
Kobiela J, Bertani E, Petz W, Crosta C, De Roberto G, Borin S, Ribero D, Baldassari D, Spychalski P, Spinoglio G. Double indocyanine green technique of robotic right colectomy: Introduction of a new technique. J Min Access Surg [serial online] 2019 [cited 2020 Jul 8];15:357-9. Available from: http://www.journalofmas.com/text.asp?2019/15/4/357/235399
| ¤ Introduction|| |
Complete mesocolic excision (CME) with central vascular ligation (CVL) was first described by Hohenberger et al. and Bokey et al. The technique involves dissection of the entire mesocolon between the embryonic planes. Patient outcomes show that compared to previously performed procedures, CME reduces local recurrence from 6.5% to 3.6% and shows improved survival rates, especially for Stage 3 patients (27% of survival advantage at 5 years). Subsequent studies have proved the feasibility and safety of the CME technique in both open and MI right colon surgery, with promising long-term oncologic outcomes., Since 1997, we have routinely performed open and MI right colectomies for cancer with radical lymphadenectomy and CVL using a technique recently described as 'modified CME' (mCME). In a recently published series of 100 cases of robotic right colectomy using mCME and intracorporeal anastomosis for right-sided colon cancer during a median follow-up period of 48.5 months, the survival rates were 94.5% for disease-specific survival, 91.4% for disease-free survival and 90.3% for overall survival. Thus, proving the feasibility and safety of robotic mCME for the treatment of right-sided colon cancer.
Firefly technology embodied in the Vinci Xi ® system offers to make surgical performance even safer and easier. Intraoperative indocyanine green (ICG) fluorescence can provide valuable information translating into the patients' benefits. Herein, we present an improved technique of robotic mCME with double ICG fluorescence administration routinely used in our institution since 2016. The technique has so far been used in over 50 patients. Evaluation of long-term oncological benefits is warranted.
| ¤ Patients/Materials and Methods|| |
Patients with right-sided colorectal cancer (CRC) undergo standard pre-operative workup and preparation. This includes on day before the surgery, an endoscopic blue dye injection in the submucosa around the tumour for intraoperative tumour localisation in the white light. In addition, a total of 6 ml of an ICG solution (3 mg) is injected endoscopically into four spots around the tumour in the submucosa for intraoperative lymph node mapping with near-infrared (NIR) fluorescence DaVinci ® imaging system. A robotic right hemicolectomy is carried out according to robotic mCME with CVL as previously described by our team. Tumour localisation is based on blue dye identification in white light enhanced by NIR fluorescence of ICG. The lymph nodes are removed en bloc by a standard lymphadenectomy; however, they are removed with the 'berry-picking' technique when detected with ICG fluorescence outside standard lymphadenectomy area (right gastroepiploic LN, pancreatic head LN and around left branches of SMA) [Figure 1]e, [Figure 1]f. With robotic ICG system, the lymph nodes and lymph vessels that contain ICG appear as shining fluorescent spots and streams in the fluorescence image [Figure 1]b, [Figure 1]c, [Figure 1]d, [Figure 1]f. Subsequently, ICG is intraoperatively administered intravenously (mean of 3.0 mL [range 2–4 mL] ICG solution [2.5 mg/mL]) to objectively assess colon perfusion before bowel anastomosis. After a short time (approximately 30–60 s), perfusion to the colon and terminal ileum is visually confirmed with NIR fluorescence DaVinci ® imaging system [Figure 2]a, [Figure 2]b. In cases of malperfusion, the resection is extended. Facultatively, intravenous ICG administration can be performed during/after the creation of stapled anastomosis to confirm adequate perfusion of the anastomosis [Figure 2]c, [Figure 2]d.
|Figure 1: Visualisation of lymph nodes and vessels with indocyanine green injected into pre-operative endoscopy (a and b) Anterior view of the mesocolon (c and d) Posterior view of the mesocolon (e and f) Lymph node outside (to the left) of the resection margin. Left: White light view, Right: Near-infrared light view|
Click here to view
|Figure 2: Visualisation of blood supply to the terminal ileum and transverse colon after intraoperative intravenous injection of indocyanine green (a and b) Before anastomosis (c and d) During anastomosis. Left: White light view, Right: Near-infrared light view|
Click here to view
| ¤ Results|| |
The presented technique is feasible and safe. Visualisation of the lymph nodes with ICG facilitates standard mCME lymphadenectomy and enables extended lymphadenectomy. Blood flow of the intestinal walls of the anastomotic site can be assessed and determines the extent of intestinal resection. Therefore, it offers potential oncologic benefit to the CRC patients incorporating the benefits of mCME with CLV, robotic mini-invasivity, fluorescence lymph node mapping and real-time assessment of the blood flow of the anastomosed intestinal walls.
| ¤ Discussion|| |
We introduce a novel technique of double ICG administration during robotic right hemicolectomy for CRC cancer that enables improved lymphadenectomy and warrants the extent of intestinal resection. It contains the intrinsic solution to the potential risks related to more intense dissection for extended lymphadenectomy. This is an immediate assessment of blood supply to the anastomosed intestinal walls.
ICG fluorescence has immanent advantages as a result of its very low toxicity, high sensitivity, fast feedback and absence of radiation. It is helpful to determine the extent of a bowel resection and can avoid leaving positive lymph nodes behind. It was revealed that ICG accurately evaluate the blood supply to anastomotic sites in real-time and can detect organ ischemia before reconstruction is performed. This is particularly useful in MI surgery, as detection of impaired blood supply is difficult and even more for intracorporeal anastomosis. Lower anastomotic leak and reoperation rate were revealed with the use of ICG in several studies.
Lymph nodes' metastases are the most important prognostic factor in CRC, which has a poor prognosis and high recurrence. The use of ICG in identification of lymph flow and lymphadenectomy basin in CRC patients has been previously reported. Lymph drainage of the right-side colon is complicated, and understanding this lymphatic drainage system is difficult, making ICG fluorescence particularly useful in right-sided CRC patients. Although there are reports of an 18.9% rate of upstaging of micrometastases, no lymphatic understaging has been reported with the use of ICG fluorescence. In a study from Japan, planned lymphadenectomy was changed in 23.5% of cases with the use of ICG.
The presented technique has some limitations. ICG fluorescence is not yet a quantitative but only a qualitative method; thus, the visual assessment is on surgeon's discretion. Further, we do not evaluate washout, i.e., the venous outflow is an important factor as a cause of the late leaks. However, fluorescence is the only objective technique available to reveal the viability of the tissues. Another limitation is a rapid diffusion of ICG to surrounding tissues that, in some cases, can obscure view and make judgement and interpretation somewhat uncertain.
| ¤ Conclusions|| |
We believe that double application of ICG in robotic right hemicolectomy for lymph node mapping and blood flow evaluation provides the surgeon an important tool to optimise the staging and treatment of right-sided CRC patients. The proposed procedure could improve radicality throughout extended lymphadenectomy but also ensure accurate staging, and therefore, subsequent oncological management. It seems a strong candidate for gold standard in robotic resections of the right colon for CRC; however, further RCS with long-term follow-up is needed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| ¤ References|| |
Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: Complete mesocolic excision and central ligation – Technical notes and outcome. Colorectal Dis 2009;11:354-64.
Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC, et al.
Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 2003;46:860-6.
Bokey EL, Ojerskog B, Chapuis PH, Dent OF, Newland RC, Sinclair G, et al.
Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: Role of total anatomical dissection. Br J Surg 1999;86:1164-70.
West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P, et al.
Pathology grading of colon cancer surgical resection and its association with survival: A retrospective observational study. Lancet Oncol 2008;9:857-65.
Siani LM, Pulica C. Stage I-IIIC right colonic cancer treated with complete mesocolic excision and central vascular ligation: Quality of surgical specimen and long term oncologic outcome according to the plane of surgery. Minerva Chir 2014;69:199-208.
Bertelsen CA, Neuenschwander AU, Jansen JE, Wilhelmsen M, Kirkegaard-Klitbo A, Tenma JR, et al.
Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: A retrospective, population-based study. Lancet Oncol 2015;16:161-8.
Cho MS, Baek SJ, Hur H, Soh Min B, Baik SH, Kyu Kim N, et al.
Modified complete mesocolic excision with central vascular ligation for the treatment of right-sided colon cancer: Long-term outcomes and prognostic factors. Ann Surg 2015;261:708-15.
Spinoglio G, Marano A, Bianchi PP, Priora F, Lenti LM, Ravazzoni F, et al.
Robotic right colectomy with modified complete mesocolic excision: Long-term oncologic outcomes. Ann Surg Oncol 2016;23:684-91.
Marano A, Priora F, Lenti LM, Ravazzoni F, Quarati R, Spinoglio G, et al.
Application of fluorescence in robotic general surgery: Review of the literature and state of the art. World J Surg 2013;37:2800-11.
Nishigori N, Koyama F, Nakagawa T, Nakamura S, Ueda T, Inoue T, et al.
Visualization of lymph/Blood flow in laparoscopic colorectal cancer surgery by ICG fluorescence imaging (Lap-IGFI). Ann Surg Oncol 2016;23 Suppl 2:S266-74.
Sujatha-Bhaskar S, Jafari MD, Stamos MJ. The role of fluorescent angiography in anastomotic leaks. Surg Technol Int 2017;30:83-8.
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
Hirche C, Mohr Z, Kneif S, Doniga S, Murawa D, Strik M, et al.
Ultrastaging of colon cancer by sentinel node biopsy using fluorescence navigation with indocyanine green. Int J Colorectal Dis 2012;27:319-24.
Spasojevic M, Stimec BV, Dyrbekk AP, Tepavcevic Z, Edwin B, Bakka A, et al.
Lymph node distribution in the d3 area of the right mesocolon: Implications for an anatomically correct cancer resection. A postmortem study. Dis Colon Rectum 2013;56:1381-7.
Resch A, Langner C. Lymph node staging in colorectal cancer: Old controversies and recent advances. World J Gastroenterol 2013;19:8515-26.
[Figure 1], [Figure 2]